Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
G protein-coupled receptor 62 (GPR62) is an orphan member of the rhodopsin-like Class A family of G protein-coupled receptors, characterized by seven transmembrane domains and cellular localization to the membrane. Like other GPCRs, GPR62 is presumed to participate in signal transduction across the plasma membrane in response to extracellular cues. Its endogenous ligand, physiological function, and involvement in disease remain uncharacterized, although orphan GPCRs as a class are actively scrutinized for therapeutic potential in neurological and metabolic diseases. GPR62’s sequence and predicted topology align it with broad GPCR molecular and structural features, making it a candidate for future drug discovery and biomedical research.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on G protein-coupled receptor 62 (GPR62).